# A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

> **NCT01379586** · PHASE1 · TERMINATED · sponsor: **Ono Pharmaceutical Co., Ltd.** · enrollment: 15 (actual)

## Conditions studied

- Healthy Adult Subjects

## Interventions

- **DRUG:** ONO-4053
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01379586
- **Lead sponsor:** Ono Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2011-07
- **Final completion:** —
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01379586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01379586, "A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01379586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*